Akebia Therapeutics AKBA
NASDAQ AKBA
$0.87 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Akebia Therapeutics (AKBA) Depreciation and Depletion (2013 - 2026)

Updated

Akebia Therapeutics' Depreciation and Depletion came in at $585,000 for Q2 2026, up 85.1% from $316,000 a year earlier and up 78.4% from the prior quarter.

Analysis

Akebia Therapeutics (AKBA) Depreciation and Depletion (2013 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Akebia Therapeutics reported Depreciation and Depletion of $1.55 million, up 16.9% year-over-year; for FY2025, it was $1.27 million, down 13.2% from FY2024.

  • Depreciation and Depletion has declined in each of the last six years, with a five-year compound annual growth rate of -9.6% (FY2020 to FY2025).
  • Going back by year, Depreciation and Depletion was $1.46 million in FY2024 (-7.8%), $1.59 million in FY2023 (-4.2%), $1.65 million in FY2022 (-12.9%) and $1.9 million in FY2021 (-9.5%).
  • The Q2 2026 figure represents the highest quarterly Depreciation and Depletion since Q3 2019.
  • Year-over-year, Depreciation and Depletion increased in two of the last eight quarters, with growth averaging 1.9%.
  • The fastest year-over-year change in Depreciation and Depletion over five years came in Q2 2026 (growth of 85.1%), and the weakest in Q2 2025 (a decline of 21.0%).
  • Business Quant data shows AKBA's Depreciation and Depletion at $328,000 (Q1 2026), $321,000 (Q4 2025) and $318,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 194.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 98.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Akebia Therapeutics 236.42 Mn -433.06 Mn 38.70 Mn 585,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 585,000.00
Mar 31, 2026 328,000.00
Dec 31, 2025 321,000.00
Sep 30, 2025 318,000.00
Jun 30, 2025 316,000.00
Mar 31, 2025 314,000.00
Dec 31, 2024 335,000.00
Sep 30, 2024 363,000.00
Jun 30, 2024 400,000.00
Mar 31, 2024 364,000.00
Dec 31, 2023 394,000.00
Sep 30, 2023 396,000.00
Jun 30, 2023 397,000.00
Mar 31, 2023 398,000.00
Dec 31, 2022 408,000.00
Dec 31, 2020 500,000.00
Sep 30, 2020 500,000.00
Jun 30, 2020 500,000.00
Mar 31, 2020 500,000.00
Dec 31, 2019 500,000.00
API Access

Akebia Therapeutics Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=AKBA&period=max&api_key=YOUR_API_KEY